Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03409146 · ClinicalTrials.gov registry record
Accuracy and Reliability of Novii: Fetal Heart Rate (FHR), Maternal Heart Rate (MHR) and Uterine Contraction (UA) Compared With Doppler, Scalp Fetal Scalp Electrode (FSE), Tocodynamometer (TOCO) and Intra Uterine Pressure Catheter (IUPC)
A clinical trial, sponsored by GE Healthcare.
- Completed
- Registry status
- 80
- Enrollment target
NCT03409146 is a clinical trial that has completed, run by GE Healthcare. The registered enrollment target is 80 participants.
The verdict
NCT03409146 has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
Accuracy and Reliability of the Novii device (fetal heart rate, maternal heart rate and uterine activity) compared with Food and Drug Administration (FDA) approved techniques
Interventions
- DEVICE Monica Novii Wireless Patch System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-05-28 |
| Est. Completion | 2017-02-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03409146
The ClinicalTrials.gov registry entry for NCT03409146 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Monica Novii Wireless Patch System is the first listed.
NCT03409146 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03409146 about?
NCT03409146 is a clinical study titled "Accuracy and Reliability of Novii: Fetal Heart Rate (FHR), Maternal Heart Rate (MHR) and Uterine Contraction (UA) Compared With Doppler, Scalp Fetal Scalp Electrode (FSE), Tocodynamometer (TOCO) and Intra Uterine Pressure Catheter (IUPC)". Accuracy and Reliability of the Novii device (fetal heart rate, maternal heart rate and uterine activity) compared with Food and Drug Administration (FDA) approved techniques
What is the current status of trial NCT03409146?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2014-05-28. Estimated completion is 2017-02-13.
What interventions are being tested in trial NCT03409146?
The interventions under investigation include: Monica Novii Wireless Patch System (DEVICE).
Who is sponsoring clinical trial NCT03409146?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.